Prot #NU 16C02: A Phase 2, Single arm, Multi-center, Open Label Trial Combining Optune with Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma

Project: Research project

Status	Active
Effective start/end date	6/3/16 → 6/1/25

Project Details